Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Seer, Inc. SEER
$3.15
-$0.14 (-4.55%)
На 18:03, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
218799034.00000000
-
week52high
13.40
-
week52low
3.07
-
Revenue
14685000
-
P/E TTM
-3
-
Beta
1.25426800
-
EPS
-1.55000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 20:00
Описание компании
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Equal-Weight | Equal-Weight | 11 авг 2022 г. |
| JP Morgan | Neutral | Overweight | 11 авг 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 05 мая 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 01 мар 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 15 февр 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 10 ноя 2022 г. |
| B of A Securities | Underperform | Neutral | 04 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Farokhzad Omid | D | 399123 | 4800 | 17 янв 2023 г. |
| Horn David R. | D | 270840 | 2602 | 17 янв 2023 г. |
| Horn David R. | D | 273442 | 18884 | 08 дек 2022 г. |
| Farokhzad Omid | D | 151764 | 59171 | 08 ноя 2022 г. |
| Farokhzad Omid | A | 392763 | 59171 | 08 ноя 2022 г. |
| Ronaghi Mostafa | A | 29640 | 29640 | 15 июн 2022 г. |
| Ronaghi Mostafa | A | 201460 | 9945 | 15 июн 2022 г. |
| Nishar Dipchand | A | 29640 | 29640 | 15 июн 2022 г. |
| Nishar Dipchand | A | 9945 | 9945 | 15 июн 2022 г. |
| MCGUIRE TERRANCE | A | 29640 | 29640 | 15 июн 2022 г. |
Новостная лента
Seer to Present at the J.P. Morgan 41st Annual Health Care Conference
GlobeNewsWire
27 дек 2022 г. в 16:05
REDWOOD CITY, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference.
Seer, Inc. (SEER) Reports Q3 Loss, Tops Revenue Estimates
Zacks Investment Research
08 ноя 2022 г. в 21:04
Seer, Inc. (SEER) delivered earnings and revenue surprises of 0% and 6.60%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Seer, Inc. (SEER) CEO Omid Farokhzad on Q3 2022 Results - Earnings Call Transcript
Seeking Alpha
08 ноя 2022 г. в 20:42
Seer, Inc. (NASDAQ:SEER ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Carrie Mendivil - IR Omid Farokhzad - Chair and CEO David Horn - CFO Conference Call Participants Dan Brennan - Cowen Derik De Bruin - Bank of America Neel Ram - Morgan Stanley Operator Good day and thank you for standing by. Welcome to the Seer Inc. Third Quarter 2022 Earnings Call.
Seer to Report Third Quarter 2022 Financial Results on November 8, 2022
GlobeNewsWire
13 окт 2022 г. в 16:15
REDWOOD CITY, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the third quarter of 2022 on Tuesday, November 8, 2022. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Seer to Participate in the Morgan Stanley Global Healthcare Conference
GlobeNewsWire
30 авг 2022 г. в 16:05
REDWOOD CITY, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming Morgan Stanley Global Healthcare Conference in New York City, New York.